The physiological responses of mammals to parasitic infection is largely determined not by factors intrinsic to the invading parasite, but rather by the activity of host cells which synthesize and release a variety of cytokines and other endogenous mediators. The physiological """"""""sum"""""""" of cellular and metabolic changes in the host that result from this interacting network of endogenous mediators must be beneficial in resolving the infection, but if this cytokine response is poorly modulated, the host can be precipitated into a potentially lethal chronic wasting syndrome known as """"""""cachexia."""""""" Most but not all of the pathological features of cachexia can now be largely attributed to the release and activity of a single cytokine, originally identified by us as """"""""cachectin"""""""" and now known to be identical to tumor necrosis factor (TNF). Work done during the previous grant period revealed that patients with malaria infections have elevated serum TNF levels lingering many months after their successful anti-parasitic treatment. This led to the hypothesis that the very stable malaria pigment hemozoin might be triggering TNF production in malarial infections. Preliminary studies have revealed that in contrast to all other macrophage stimulators studied to date (where TNF production is limited to the first few hours), malaria pigment induces a linear increase in TNF lasting for at least three days. This is a unique attribute of hemozoin that indicates qualitative and quantitative differences in the parasite-elicited cytokine response versus the now better known response to bacterial endotoxin. One of our major aims is to characterize the molecular mechanism underlying these differences in vitro and in vivo. Despite our own vigorous past efforts and those of a number of other investigators, neither TNF itself, nor any other known cytokine, nor any combination of known mediators can account for the induction of net muscle protein catabolism that is a hallmark of cachectic pathology. For this and other reasons, we have advanced the novel hypothesis that immune system cells, particularly macrophages, mediate the induction of net whole body nitrogen loss by upregulating their production of urea, and that the loss of muscle protein in cachexia directly reflects the consequent mobilization and catabolism of amino acids from the tissues to satisfy this irreversible depletion of available nitrogen. Thus a second major aim of this proposal is to determine the existence, consequences, and regulation of this catabolic mechanism in vivo and in vitro. Ultimately, we hope to use these mechanistic insights to devise new strategies and reagents for clinical use against the ravages of parasitic disease and its associated cachexia.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI021359-11
Application #
2061483
Study Section
Tropical Medicine and Parasitology Study Section (TMP)
Project Start
1985-09-01
Project End
1999-06-30
Budget Start
1995-07-01
Budget End
1996-06-30
Support Year
11
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Picower Institute for Medical Research
Department
Type
DUNS #
City
Manhasset
State
NY
Country
United States
Zip Code
11030
Sherry, B; Espinoza, M; Manogue, K R et al. (1998) Induction of the chemokine beta peptides, MIP-1 alpha and MIP-1 beta, by lipopolysaccharide is differentially regulated by immunomodulatory cytokines gamma-IFN, IL-10, IL-4, and TGF-beta. Mol Med 4:648-57
Lan, H Y; Yang, N; Metz, C et al. (1997) TNF-alpha up-regulates renal MIF expression in rat crescentic glomerulonephritis. Mol Med 3:136-44
Calandra, T; Bucala, R (1997) Macrophage migration inhibitory factor (MIF): a glucocorticoid counter-regulator within the immune system. Crit Rev Immunol 17:77-88
Cohen, P S; Nakshatri, H; Dennis, J et al. (1996) CNI-1493 inhibits monocyte/macrophage tumor necrosis factor by suppression of translation efficiency. Proc Natl Acad Sci U S A 93:3967-71
Lolis, E; Bucala, R (1996) Crystal structure of macrophage migration inhibitory factor (MIF), a glucocorticoid-induced regulator of cytokine production, reveals a unique architecture. Proc Assoc Am Physicians 108:415-9
Schmidtmayerova, H; Nottet, H S; Nuovo, G et al. (1996) Human immunodeficiency virus type 1 infection alters chemokine beta peptide expression in human monocytes: implications for recruitment of leukocytes into brain and lymph nodes. Proc Natl Acad Sci U S A 93:700-4
Bucala, R (1996) MIF rediscovered: cytokine, pituitary hormone, and glucocorticoid-induced regulator of the immune response. FASEB J 10:1607-13
Sherry, B A; Alava, G; Tracey, K J et al. (1995) Malaria-specific metabolite hemozoin mediates the release of several potent endogenous pyrogens (TNF, MIP-1 alpha, and MIP-1 beta) in vitro, and altered thermoregulation in vivo. J Inflamm 45:85-96
Calandra, T; Bucala, R (1995) Macrophage migration inhibitory factor: a counter-regulator of glucocorticoid action and critical mediator of septic shock. J Inflamm 47:39-51
Calandra, T; Bernhagen, J; Mitchell, R A et al. (1994) The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J Exp Med 179:1895-902

Showing the most recent 10 out of 35 publications